AccessDx Hereditary Cancer Testing (CGx)

Identifying Hereditary Cancer Risk with Genetic Testing

The AccessDx Hereditary Cancer (CGx) screening assay is aimed to detect the causative variants involved in the most common hereditary cancers. These genomic targets were chosen to cover the presence of the genetic variants base on levels of clinical evidence linked to the hereditary cancers with relatively high occurrence in the United States population. 

Hereditary Cancer cover

AccessDx Hereditary Cancer Testing (CGx)

The AccessDx Laboratory NGS-based Hereditary Cancer test is a custom designed panel that includes 33 genes known to harbor variants linked to the hereditary cancer syndrome.

Download the PDF

Experience a New Standard
in Lab Diagnostics

Contact Us